Shire gets injunction against Roche over hemophilia drug

ZURICH (Reuters) – Pharmaceutical group Shire said on Sunday it had obtained a preliminary injunction in a Hamburg court against rival Roche over its hemophilia drug emicizumab, alleging incomplete and misleading statements surrounding the treatment.

Source: Reuters Business News